chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Panic disorder
Clinical narrative: Magnets are sticking to her arm/ started to get a little panicked when the magnet stuck to her arm; Magnets are sticking to her arm/ started to get a little panicked when the magnet stuck to her arm; This is a spontaneous report from a contactable consumer (Patient). A 42-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Right on 17May2021 (at the age of 42-year-old) as 2ND DOSE, SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported. Family medical history relevant to AE and relevant tests was none. The patient did not emergency room and physician Office. The patient previously took first dose of BNT162B2 administered in Arm Right for COVID-19 immunization on 20Apr2021 and experienced headache. The patient experienced Magnets are sticking to her arm/ started to get a little panicked when the magnet stuck to her arm on 17May2021. It was reported that patient was received the second dose of the vaccine on 17May2021, and she reported that she experiences magnets are sticking to her arm on 17May2021, she also mentioned that a coworker has been experiencing the same thing. It was reported that the caller verified the information provided by the transferring agent. She would not believe it and saw videos of it online and tried it after she got it. She said that it physically happened to her and she said that she can feel the magnet pulling on her arm. She was concerned about something being in there that does not belong. She can feel the pull of the magnet. It was reported that She started to get a little panicked when the magnet stuck to her arm and it kept happening. It was reported by the caller it held a fairly heavy magnet. The seriousness of the events was reported as non-serious. The outcome for events was not recovered.  Information about batch/lot number has been requested.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Aphthous ulcer
Clinical narrative: lesions on the top of her mouth/It feels like the tissue is coming off the top of her mouth; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team. A 66-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: WE0177; Expiration Date: 31Aug2021), via an unspecified route of administration, administered in left arm on 18May2021 19:30 (at the age of 66-year-old) at single dose for Covid prevention. The patient medical history was not reported. Concomitant medication included pantoprazole sodium sesquihydrate (PANTOPRAZOLE 40mg) orally at 40mg daily for acid reflux (has been taking several years). No history of previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines administered on same date of the Pfizer suspect. No prior vaccinations within four weeks prior to the first administration date of the suspect vaccine. On 19May2021 (Today as reported), she developed lesions on the top of her mouth and was reported as worsened. She wanted to know if that is a normal reaction. It feels like the tissue is coming off the top of her mouth. The outcome of event was not recovered.  No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Headache; Tired; This is a spontaneous report from a Pfizer  A contactable consumer (patient's wife).   A male patient of an unspecified age received both doses of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as SINGLE DOSE, for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Other products were not reported. Caller reported that her husband, the patient, took both doses of the Covid-19 vaccine with very minimal, usual side effects. Caller declined to complete safety report. Caller reported that the patient experienced just the usual, expected side effects. Caller reported that the on unspecified date the patient had a headache and was just tired. The outcome of the event was reported as unknown.  Information on the lot/batch number has been requested. Further Information is expected.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Contracted COVID; Contracted COVID; This is spontaneous report from a contactable consume (patient son). An 84-year-old female patient (mother) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose for COVID-19 immunization, the first dose was on an unspecified date, the second dose was on 26Mar2021. Medical history and concomitant medication were not reported. Patient recently had her second vaccine for COVID. She had no side effects and was in good spirits. In late April, she was hospitalized, discharged on 26Apr2021, reason for hospitalization was unspecified. Currently she was in Hospice care and contracted COVID. The outcome of events was unknown.  The information on the lot/batch number has been requested.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: made her arm sore and made her tired for a few days; made her arm sore and made her tired for a few days; This is a spontaneous report from a contactable consumer, the Patient, from a Pfizer sponsored program. A 71-year-old female patient received first dose of BNT162B2 (PFIZER BIONTECH COVID-19 Vaccine, Lot number: EW0161(Then it says U682 or it says UU82 or 6682), Expiration date: Unknown), via an unspecified route on 22Apr2021 as a single dose for covid-19 immunization. Medical history included blood pressure, cholesterol medication and osteoporosis. The Alprazolam, Effexor, Cymbalta and Togranil all for Antidepressant, Celexa for pain (stool blockage, stool was sitting in colon, bad cramps while taking. take therapy for 2 to 3 months) and Xanax for Panic attack. The patient's concomitant medications were not reported. She had the first shot and it did not bother her. It made her arm sore and made her tired for a few days. The outcome of the event was unknown.   Follow-up attempts are needed; Additional information has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Myalgia
Clinical narrative: headache; muscle ache; dizziness; This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer (patient) reported that a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 08Apr2021 as 1st dose, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 08Apr2021, the patient experienced headache, muscle ache, dizziness. The patient took Tylenol as treatment after the first dose. The outcome of the events was unknown.  Information about batch/lot number has been requested.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Diarrhoea, Dysgeusia, Dyspnoea
Clinical narrative: She had Covid 19 virus symptoms; shortness of breath; heart is racing; chills; she feels her mouth as if she had eaten too much salt; diarrhea; Feet pain; This is a spontaneous report from a contactable consumer or other non-HCP. A 59-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0170), via an unspecified route of administration, administered on Left Arm on 14May2021 09:00 at single dose for covid-19 immunization (to protect herself from the virus). The patient's Medical history and concomitant medications were not reported. The Family Medical History Relevant to events was reported as none. The patient has not received any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0172) via unspecified route of administration administered on Left Arm on 23Apr2021 for COVID-19 immunization. On 14May2021 14:00 the patient experienced shortness of breath, heart is racing, chills, she feels her mouth as if she had eaten too much salt, diarrhea, feet pain. Upon received follow-up information on 20May2021, it was reported that On 18May2021 the patient experienced She was told she had Covid 19 virus symptoms and if her symptoms persisted to keep treating herself at home. The doctor did not perform a Covid 19 virus test. It was reported that About 5 hours after receiving her second Covid 19 vaccine, the patient experienced the events. The events resulted in physician visit. The relevant tests was reported as none. The outcome of event she had covid 19 virus symptoms was unknown, while rest of events was not recovered.  Follow up(20May2021): New Information received from the Pfizer colleague includes new adverse event details, anatomical location of both doses details.  Follow up(20May2021): Upon follow up, no new information has been included.  Information about Lot/Batch number is available. Further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Palpitations
Clinical narrative: She had Covid 19 virus symptoms; shortness of breath; heart is racing; chills; she feels her mouth as if she had eaten too much salt; diarrhea; Feet pain; This is a spontaneous report from a contactable consumer or other non-HCP. A 59-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0170), via an unspecified route of administration, administered on Left Arm on 14May2021 09:00 at single dose for covid-19 immunization (to protect herself from the virus). The patient's Medical history and concomitant medications were not reported. The Family Medical History Relevant to events was reported as none. The patient has not received any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0172) via unspecified route of administration administered on Left Arm on 23Apr2021 for COVID-19 immunization. On 14May2021 14:00 the patient experienced shortness of breath, heart is racing, chills, she feels her mouth as if she had eaten too much salt, diarrhea, feet pain. Upon received follow-up information on 20May2021, it was reported that On 18May2021 the patient experienced She was told she had Covid 19 virus symptoms and if her symptoms persisted to keep treating herself at home. The doctor did not perform a Covid 19 virus test. It was reported that About 5 hours after receiving her second Covid 19 vaccine, the patient experienced the events. The events resulted in physician visit. The relevant tests was reported as none. The outcome of event she had covid 19 virus symptoms was unknown, while rest of events was not recovered.  Follow up(20May2021): New Information received from the Pfizer colleague includes new adverse event details, anatomical location of both doses details.  Follow up(20May2021): Upon follow up, no new information has been included.  Information about Lot/Batch number is available. Further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Off label use, Rash, Swelling face, Swelling of eyelid
Clinical narrative: Why was the patient taking Covid-19 vaccine (Verbatim): because she is diabetic; swelling under eyelids; swelling on chin and left cheek; had an allergic reaction with  a rash; rash from neck up on chin and cheeks; This is a spontaneous report from a contactable reporter(patient herself). A 49-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0176) via an unspecified route of administration, administered in right arm on 29Apr2021 at 14:30 as single dose for COVID-19 immunization. Other vaccinations within four weeks prior to the first administration date of the suspect vaccine was reported as none. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) was reported as none. AE(s) following prior vaccinations was reported as none. Medical history included type 2 diabetes mellitus. It was reported that she ran out of medication and was not taking anything for diabetes.  Family Medical History Relevant to AE(s) included that her father had a positive result after getting the vaccine. Her father has rheumatoid arthritis including pain all over. After getting the vaccine, the pain went away. Her father also had a rash on his arm that cleared up after getting the vaccine. No relevant tests were done as reported. Concomitant medication included Azo from 27 Apr 2021, ongoing and Nervive taken for nerve relief from 27 Apr 2021 and stopped taking it on 03 May 2021. It was reported that she was fine but had an allergic reaction with a rash from her neck up that was on her chin and cheeks around 1700-1800 on 29Apr2021. She had swelling under her eyelids on 30Apr2021 and on the bottom of her cheek on 30Apr2021. It was also reported that the patient took Covid-19 vaccine because she is diabetic. She was scheduled to get the second injection today(20May2021) and was asking if she should get it. She mentioned that she does not have a physician. She thought she had a reaction to it. Lot 1069C95021, Expiry Feb 2023.. The outcome of the events, off label use was unknown and rash from neck up on chin and cheeks and swelling on chin and left cheek was recovered on 11May2021, rash from neck up on chin and cheeks was recovered on 03May2021.  Follow up attempts are needed. Further information has been requested.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Contusion, Headache, Pain, Pyrexia
Clinical narrative: Headache; Fever; Chills; I am aching; Little tenderness in my left cap, feels like little bruise; Little tenderness in my left cap, feels like little bruise; This is a spontaneous report from a contactable consumer or other non hcp.   A 55-years-old female patient received the first dose of BNT162B2 (Formulation: solution for injection; Batch/Lot Number: EW0177) via an unspecified route of administration on 18May2021 (at age of 55-years-old ) as a single dose for COVID-19 immunization. Medical history included COVID-19 in Mar2020. Concomitant medication(s) included paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported. On 19May2021, the patient experienced headache, fever, chills, i am aching and little tenderness in my left cap, feels like little bruise. The patient woke up this morning with the terrible headache and took 2 Tylenol in the morning then took 2 Tylenol in the afternoon. So, the patient haven't had any Tylenol since about 2 o clock this afternoon and the patient had a fever now. The patient just didn't expect to feel sick after the first shot, the girl who administered the vaccine asked me if the patient had COVID before and the patient had COVID in Mar 2020, so she said some people who previously had COVID experience side effects after the first shot. The patient was concerned because still (on day of reporting) had really bad headache and fever and the chills and was aching. The patient took Tylenol and went to bed, drink water. The patient also had little tenderness in left cap, felt like little bruise. The outcome of events was unknown.  Information on Lot/batch number is available; Further information has been requested.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: Headache; Fever; Chills; I am aching; Little tenderness in my left cap, feels like little bruise; Little tenderness in my left cap, feels like little bruise; This is a spontaneous report from a contactable consumer or other non hcp.   A 55-years-old female patient received the first dose of BNT162B2 (Formulation: solution for injection; Batch/Lot Number: EW0177) via an unspecified route of administration on 18May2021 (at age of 55-years-old ) as a single dose for COVID-19 immunization. Medical history included COVID-19 in Mar2020. Concomitant medication(s) included paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported. On 19May2021, the patient experienced headache, fever, chills, i am aching and little tenderness in my left cap, feels like little bruise. The patient woke up this morning with the terrible headache and took 2 Tylenol in the morning then took 2 Tylenol in the afternoon. So, the patient haven't had any Tylenol since about 2 o clock this afternoon and the patient had a fever now. The patient just didn't expect to feel sick after the first shot, the girl who administered the vaccine asked me if the patient had COVID before and the patient had COVID in Mar 2020, so she said some people who previously had COVID experience side effects after the first shot. The patient was concerned because still (on day of reporting) had really bad headache and fever and the chills and was aching. The patient took Tylenol and went to bed, drink water. The patient also had little tenderness in left cap, felt like little bruise. The outcome of events was unknown.  Information on Lot/batch number is available; Further information has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Asthenia, Computerised tomogram, Gait disturbance, Heart rate
Clinical narrative: Fever; hair loss; trouble walking; lack of energy; high heart rate; This is a spontaneous report from a contactable consumer (patient), based on information received by Pfizer from Bristol-Myers Squibb (manufacturer control number US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-042611). This case was split from master case AER #2021577283 to capture a female patient taking BNT162B2 and experienced fever, hair loss, trouble walking, lack of energy and a high heart rate.  A 70-years-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on an unspecified date as unknown, single (received her COVID vaccine since being diagnosed) for COVID-19 immunisation. Medical history included ongoing COVID-19 (does not know where she got COVID) and hospitalisation (for COVID and while in the hospital started on ELIQUIS for blood clots that where found in her lungs). Concomitant medication(s) included apixaban (ELIQUIS) oral taken for pulmonary embolism twice a day (batch no. 1796051); ascorbic acid; colecalciferol and zinc. On an unspecified date, the patient experienced fever, hair loss, trouble walking, lack of energy and high heart rate. The patient underwent lab tests and procedures which included computerised tomogram: lungs look much better, had scaring on lungs from COVID but did not see any blood clots on 29Apr2021 and heart rate: high on an unspecified date. The outcome of the events were unknown.
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Pyrexia
Clinical narrative: Fever; hair loss; trouble walking; lack of energy; high heart rate; This is a spontaneous report from a contactable consumer (patient), based on information received by Pfizer from Bristol-Myers Squibb (manufacturer control number US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-042611). This case was split from master case AER #2021577283 to capture a female patient taking BNT162B2 and experienced fever, hair loss, trouble walking, lack of energy and a high heart rate.  A 70-years-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on an unspecified date as unknown, single (received her COVID vaccine since being diagnosed) for COVID-19 immunisation. Medical history included ongoing COVID-19 (does not know where she got COVID) and hospitalisation (for COVID and while in the hospital started on ELIQUIS for blood clots that where found in her lungs). Concomitant medication(s) included apixaban (ELIQUIS) oral taken for pulmonary embolism twice a day (batch no. 1796051); ascorbic acid; colecalciferol and zinc. On an unspecified date, the patient experienced fever, hair loss, trouble walking, lack of energy and high heart rate. The patient underwent lab tests and procedures which included computerised tomogram: lungs look much better, had scaring on lungs from COVID but did not see any blood clots on 29Apr2021 and heart rate: high on an unspecified date. The outcome of the events were unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Headache, Pain
Clinical narrative: Headache after second vaccine; Body aches, after second vaccine; Temperature, feels like she is burning up, after second vaccine; This is a spontaneous report received from a contactable consumer (Patient). A 63-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection, Lot number: ER6955) intramuscular on 18May2021 in right arm as a single dose for COVID-19 immunization. Patient's medical history included angioma (Caller re-ports it has been years, and used to go for MRI's, every 6 months and angioma has haemorrhaged in the past), Emphysema (It has been years and patient has one lung), High blood pressure (caller states years ago, then clarifies as 15 years ago at least) and still ongoing. Concomitant medications included high blood pressure pills, pain pills and a Vitamin D prescription. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection, Lot number: ER8729) on 17Apr2021 in left arm as a single dose for COVID-19 immunization. Patient had no Vaccinations (within 4 weeks) prior to the first administration date of the suspect vaccine. Patient had No Family Medical History Relevant to AE(s) she doesn't have any family left, they are dead. On 19May2021, the patient experienced Headache when she woke up, about 9 am, Body aches when she woke up in the morning, Temperature of about 102.2 degrees, like it is worse, like she is burning up when she got up in the morning, after second dose of vaccine and ongoing. Patient was not visited to emergency room and physician room. Caller asks if DSU agent has any recommendations as to how she can feel better. The patient underwent lab tests and procedures which included body temperature and result 102degrees. The outcome of event was not recovered.  Information on Lot/Batch number was available. Additional information has been requested.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discomfort
Clinical narrative: a magnet will stick to her injection site.; This is a spontaneous report from a contactable other hcp. A 46-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EN5318; Expiration Date: unknown), dose 2 intramuscular, administered in Deltoid Left on 05Feb2021 as 2nd dose, 0.3 ml single dose for COVID-19 immunization. The patient took the Historical BNT162B2 vaccine on 14Jan2021 (Lot EL3248), 0.3ml, intramuscular, administered into the left deltoid. The patient medical history was not reported. The patient's concomitant medications were not reported. On 20May2021,  the patient experienced a magnet will stick to her injection site (vaccination site discomfort). The clinical outcome of the events was unknown.   Information on the lot/batch number has been requested.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Glossodynia, Headache, Lymphadenopathy, Oral pain, Pain in extremity
Clinical narrative: Headache in the back of my head; Sore on my tongue; Sore on the side of my mouth; swollen lymph nodes; sore arm; This is a spontaneous report from a contactable consumer or other non hcp. A 64-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 27Apr2021 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced headache, sore arm, swollen lymph nodes and sore in the mouth. She received the first Pfizer shot 3 weeks ago. She had a sore arm for 3 days following the dose. She's also been having a headache in back of her head since then. She says the headache stopped yesterday. She now has swollen lymph nodes and a sore in her mouth. Her second dose is scheduled next Tuesday. The outcome of the event was unknown.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Multiple allergies, SARS-CoV-2 test, Throat irritation
Clinical narrative: allergies; scratchy throat; positive for Covid; This is a spontaneous report from a contactable consumer via a Pfizer-sponsored program COVAX US Support. This consumer reported similar events for 2 patients. This is one of the 2 reports.  A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 04Feb2021 (Batch/Lot number was not reported) as 1st dose, single for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated that she and her husband received 1st shot on 04Feb2021. On an unspecified date, the patient (husband) had scratchy throat and assumed it was from allergies. Then 4 days later they both tested positive for Covid. The patient had a Covid-test on 08Feb2021 with positive result. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021294455 Same reporter, drug, and event, different patient
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discomfort
Clinical narrative: A magnet will stick to her injection site.; This is a spontaneous report from a contactable other health professional (nurse). This report is 2nd out of 9 reports. A female patient of unspecified age received bbnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: unknown), via an unspecified route of administration on unspecified date as unknown, single for COVID-19 immunization. Patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced a magnet will stick to her injection site. The nurse stated that if Pfizer had any information regarding the magnetic effects at the injection site after receiving vaccination with the Pfizer-BioNTech COVID-19 vaccine. The nurse called to report on one of her patient who knew 7 women within her friend group and within her family who were able to have a magnet stick to their injection site after receiving the Pfizer COVID vaccine. The nurse assessed the event as non-serious. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discomfort
Clinical narrative: A magnet will stick to her arm at injection site; This is a spontaneous report from a contactable Nurse. The caller knows of 8 individuals (7 females and 1 male) who have also reported. This report was 4 of 9.   A 46-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration in Deltoid Left (arm) on an unknown date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medication were not reported. On an unknown date, the patient after received COVID vaccine the patient felt magnet stuck to her arm at the injection site. The patient knows 7 women within her friend group and within her family who was able to have a magnet stick to their injection site after receiving the Pfizer COVID vaccine. Caller would like to know if Pfizer has any information or guidance regarding this. The caller does not have any more information on this event. No further information or details were captured at this time. The outcome of the event was unknown.   Information on the lot/batch number and Additional information has been requested.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discomfort
Clinical narrative: a magnet will stick to her injection site.; This is a spontaneous report from a contactable nurse. A 46-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number unknown), via an unspecified route of administration, administered in arm on an unspecified date as unknown, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter stated she had a patient (46 years old female) who has reported that after receiving the Pfizer Covid vaccine, a magnet would stick to her injection site. The 46 years old female patient knows of 8 individuals who had also reported it. Reporter would like to know if Pfizer has any information or guidance regarding this. The reporter called to report on one of her patients who stuck a magnet to their injection site after receiving the Pfizer covid vaccine, and the magnet stuck to her patient's arm. The patient knows 7 women within her friend group and within her family who was able to have a magnet stick to their injection site after receiving the Pfizer covid vaccine. There was no PQC (product quality complaint) present. The outcome of the events was reported as unknown.  Information about lot/batch number has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: the other 15 people I know including my mom, my sister, my daughter, and a bunch of friends call to report they can stick a magnet to their arm too?; lymph node swelling; This is a spontaneous report from a contactable consumer (Patient).   An unspecified years-old and gender patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route on an unspecified date, as UNKNOWN, SINGLE DOSE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date the patient stated that the other 15 people I know including my mom, my sister, my daughter, and a bunch of friends call to report they can stick a magnet to their arm too. Another family member got the Moderna vaccine, and they can do the same thing. So it is not only your vaccine, but Moderna as well. She is not one of those wackos that thinks it's a microchip, but she is sure others will. On an unspecified date, the patient experienced lymph node swelling. All the events were non-serious. The outcome of all the event were unknown.   No follow-up attempts are needed; Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: magnet sticks to the place she got the shot; This is a spontaneous report from a contactable consumer (patient's mother). A female patient (reporter's daughter) of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number; Expiry Date; NDC number: Unknown), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Reporter stated that a magnet sticks to patient's injection site/magnet sticks to the place she got the shot on an unspecified date. Her daughter could put a large or small magnet for it to hold on, and it sticks. She can feel it pulling. The outcome of event was unknown.  Information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021611456 same reporter/drug/AE, different patient
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain
Clinical narrative: Headache; Pain; This is a spontaneous report from a contactable consumer (patient's wife) reporting for a patient (her husband) via Pfizer sponsored program COVAX US Support. A 28-year-old male patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration on 20May2021 as 2nd dose single and had previously received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration as 1st dose single for COVID-19 immunization. The patient was 28-years-old at the time of vaccination. The main concern of the wife is that her husband the second dose of the vaccine on 20May and her husband experienced a bad headache and wanted to know if he can take Tylenol or Ibuprofen or any type of medicine for pain would be okay to take. While paraphrasing the concern, she stated, yes he did, she does not think it is from the Pfizer shot itself, he has been under a lot of stress at work but it is a stressful headache. The outcome of the event was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discomfort
Clinical narrative: Magnet sticks to site of injection; This is a spontaneous report received from a contactable consumer (patient's family members). The consumer reported for family members. This report is for 3 of 5 (reporting on the women).   A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not provided), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. Reporter was discussing how a magnet sticks to her injection site, at which time she mentioned that this happened to other people. Report 3 was caller reporting on the women. Reporter stated that she had a lot of family members who had a magnet stick to their site of injection, and most of them, the family members that it sticks to, are female.  Follow-up attempts are needed. Information about batch/lot number is requested.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Feeling abnormal, Headache, Influenza like illness, Pyrexia
Clinical narrative: Headache; I feel horrible/ feel this bad before this get better; I feel like I got the flu; I got a fever for over a 100; This is a spontaneous report from a contactable consumer or other non-health professional (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, lot number and expiration date were not reported), dose 2 via an unspecified route of administration on 20May2021 as 2nd dose, single for covid-19 immunisation. The patient took historical vaccination with BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, lot number and expiration date were not reported), dose 1 via an unspecified route of administration on an unspecified date for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient got second dose yesterday morning, and have all of the regular symptoms headache, fever, felt like got the flu, and got a fever for over a 100 on an unspecified date in May2021. The patient was wondering that how much longer need to feel this bad before this get better. The patient also stated that it really was not that patient felt like hell but felt horrible so some other time. Limited information was available over the call. The outcome of the events was reported as not recovered.  Information on lot/batch number has been requested.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy, Swelling of eyelid
Clinical narrative: Caller experienced swelling of the eyelid after receiving the second dose of the vaccine; swollen lymph nodes; This is a spontaneous report from a contactable consumer. A 53-years-old female patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 21May2021 as 2ND DOSE, SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) for covid-19 immunization. On 21May2021, the patient experienced swelling of the eyelid after receiving the second dose of the vaccine and also experienced swollen lymph nodes and has been using cold compresses and tea bags to remedy the swelling. Patient also mentioned that she had the photos of the AE she experienced take last Wednesday (19May2021) and yesterday (21May2021). Overall safety summary included in clinical studies, adverse reactions in participants 16 years of age and older included injection site swelling (10.5%). Clinical trials experience solicited local and systemic adverse reactions across both age groups, 18 through 55 years of age and 56 years and older, mean duration of swelling 2.3 days (range 1 to 34 days). No information found for swelling specifically in the eyelid area. Referred to HCP. The events were considered as non-serious. The outcome of events was unknown.   Follow up attempts are needed. Further information has been requested.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test, Lymphadenopathy, Swelling of eyelid
Clinical narrative: Caller experienced swelling of the eyelid after receiving the second dose of the vaccine; swollen lymph nodes; This is a spontaneous report from a contactable consumer. A 53-years-old female patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 21May2021 as 2ND DOSE, SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) for covid-19 immunization. On 21May2021, the patient experienced swelling of the eyelid after receiving the second dose of the vaccine and also experienced swollen lymph nodes and has been using cold compresses and tea bags to remedy the swelling. Patient also mentioned that she had the photos of the AE she experienced take last Wednesday (19May2021) and yesterday (21May2021). Overall safety summary included in clinical studies, adverse reactions in participants 16 years of age and older included injection site swelling (10.5%). Clinical trials experience solicited local and systemic adverse reactions across both age groups, 18 through 55 years of age and 56 years and older, mean duration of swelling 2.3 days (range 1 to 34 days). No information found for swelling specifically in the eyelid area. Referred to HCP. The events were considered as non-serious. The outcome of events was unknown.   Follow up attempts are needed. Further information has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Rhinorrhoea
Clinical narrative: runny nose/My nose was running a little bit; cold; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot Number: EW0164, Expiration date: Unknown) as 1ST DOSE, SINGLE for COVID-19 immunization. Medical history included severe allergic reaction from an unknown date and unknown if ongoing history of a severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine. There were no concomitant medications. On an unspecified date the patient experienced runny nose/my nose was running a little bit and cold. The reporter stated that she is scheduled to receive her second dose of the {Pfizer COVID-19 vaccine tomorrow, but yesterday she got wet in the rain, went into job and it was cold in there, and today has a runny nose/. my nose was running a little bit. is it okay to get vaccine tomorrow. Outcome of the events were reported as not recovered at this time of the report.  Information about batch/lot number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, SARS-CoV-2 test
Clinical narrative: First time he got a sore arm; This is a spontaneous report from a non-contactable consumer. A 51-year-old male patient (reporter's cousin) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history included as dialysis and concomitant medications were not reported. The patient experienced, first time he got a sore arm on an unspecified date. The caller started, just wondering how many days to wait before he doesn't have to wear a mask. The reporter stated, His cousin got the Pfizer covid vaccine. First time he got a sore arm. The reporter stated, first dose he didn't feel anything. After his 2nd vaccine he didn't have any adverse reactions either. His concern was, he was on dialysis. he has done 7 or 8 tests (SARS-CoV-2 test) and was tested negative. Seriousness reported as non-serious. The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Chest pain, Computerised tomogram, Dizziness, Dysarthria
Clinical narrative: sharp chest pain randomly; dizziness; slurred speech; severe joint pains; muscle pains; fast heart rate over 100 beats per min; This is a spontaneous report from a contactable consumer (patient). A 36-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 01May2021 15:00 (at the age of 36-years-old) (Batch/Lot Number: EW0172; Expiration Date: Aug2021) as single dose for COVID-19 immunisation. There were no medical history and concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since 05May2021 13.00, the patient started experiencing sharp chest pain randomly, then had dizziness and slurred speech. Went into ER to check out and looked all fine per CT scans and MRI. Few days later, he started feeling severe joint pains and muscle pains. Last few days, he had fast heart rate over 100 beats per min (before his resting heart rate was 50-60). AE resulted in Emergency room/department or urgent care and Doctor or other healthcare professional office/clinic visit. No treatment received for AE. Reporter assessed the event as non serious. Since the vaccination, the patient has been tested for COVID-19. The patient underwent lab tests and procedures which included RT-PCR, covid test post vaccination (nasal swab): Negative on 11May2021. Outcome of the events was unknown.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Heart rate, Heart rate increased, Magnetic resonance imaging, Myalgia, SARS-CoV-2 test
Clinical narrative: sharp chest pain randomly; dizziness; slurred speech; severe joint pains; muscle pains; fast heart rate over 100 beats per min; This is a spontaneous report from a contactable consumer (patient). A 36-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 01May2021 15:00 (at the age of 36-years-old) (Batch/Lot Number: EW0172; Expiration Date: Aug2021) as single dose for COVID-19 immunisation. There were no medical history and concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since 05May2021 13.00, the patient started experiencing sharp chest pain randomly, then had dizziness and slurred speech. Went into ER to check out and looked all fine per CT scans and MRI. Few days later, he started feeling severe joint pains and muscle pains. Last few days, he had fast heart rate over 100 beats per min (before his resting heart rate was 50-60). AE resulted in Emergency room/department or urgent care and Doctor or other healthcare professional office/clinic visit. No treatment received for AE. Reporter assessed the event as non serious. Since the vaccination, the patient has been tested for COVID-19. The patient underwent lab tests and procedures which included RT-PCR, covid test post vaccination (nasal swab): Negative on 11May2021. Outcome of the events was unknown.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Antinuclear antibody, Arthralgia, Blood culture, Blood test, Blood thyroid stimulating hormone
Clinical narrative: sharp chest pain randomly; dizziness; slurred speech; severe joint pains; muscle pains; fast heart rate over 100 beats per min; This is a spontaneous report from a contactable consumer (patient). A 36-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 01May2021 15:00 (at the age of 36-years-old) (Batch/Lot Number: EW0172; Expiration Date: Aug2021) as single dose for COVID-19 immunisation. There were no medical history and concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since 05May2021 13.00, the patient started experiencing sharp chest pain randomly, then had dizziness and slurred speech. Went into ER to check out and looked all fine per CT scans and MRI. Few days later, he started feeling severe joint pains and muscle pains. Last few days, he had fast heart rate over 100 beats per min (before his resting heart rate was 50-60). AE resulted in Emergency room/department or urgent care and Doctor or other healthcare professional office/clinic visit. No treatment received for AE. Reporter assessed the event as non serious. Since the vaccination, the patient has been tested for COVID-19. The patient underwent lab tests and procedures which included RT-PCR, covid test post vaccination (nasal swab): Negative on 11May2021. Outcome of the events was unknown.